IFN-γ from lymphocytes enhances the expression of PD-L1 and PD-L2 in tumor and stromal cells, which bind PD-1 on tumor-infiltrating T cells to suppress the cytotoxic response and promotes cancer progression [17, 18]. Here, PDCD1 is linked to neoplasm.